Skip to content
Disclosery

Paradigm Biocapital Advisors LP: VRDN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on VRDN, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 6,723,788 VRDN shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 6,723,788 shares
    Change vs previous 13F +3,574,895 shares

    2.31% of the 13F portfolio, value $123,515,986.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,148,893 shares
    Change vs previous 13F +1,705,791 shares

    1.26% of the 13F portfolio, value $61,592,347.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,443,102 shares
    Change vs previous 13F -1,166,251 shares

    1.2% of the 13F portfolio, value $44,909,334.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,609,353 shares
    Change vs previous 13F -132,223 shares

    1.67% of the 13F portfolio, value $56,309,838.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,741,576 shares
    Change vs previous 13F +646,497 shares

    1.64% of the 13F portfolio, value $38,327,232.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,095,079 shares
    Change vs previous 13F +275,000 shares

    1.3% of the 13F portfolio, value $28,241,665.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,820,079 shares
    Change vs previous 13F -1,075,610 shares

    1.21% of the 13F portfolio, value $34,890,914.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 2,895,689 shares
    Change vs previous 13F not available

    2.31% of the 13F portfolio, value $65,876,925.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).